SU11248 Extends Life as Sutent Miracle With $48,720 Annual Bill

Peter Hirth, a former Sugen president who helped to develop the drug Sutent, poses for a photo in his office at Plexxikon Inc., where he is currently the chief executive officer, in Berkeley, California, U.S., on Oct. 8, 2009. Hirth holds a crystallopgraphy-produced 3-D model of a melanoma drug being tested by Plexxikon. Photographer: Ken Wells/Bloomberg via Getty Images
Peter Hirth, a former Sugen president who helped to develop the drug Sutent, poses for a photo in his office at Plexxikon Inc., where he is currently the chief executive officer, in Berkeley, California, U.S., on Oct. 8, 2009. Hirth holds a crystallopgraphy-produced 3-D model of a melanoma drug being tested by Plexxikon. Photographer: Ken Wells/Bloomberg via Getty Images
SU11248 Extends Life as Sutent Miracle With $48,720 Annual Bill
PURCHASE A LICENCE
How can I use this image?
AED 1,300.00
AED
Getty ImagesSU11248 Extends Life as Sutent Miracle With $48,720 Annual Bill, News PhotoSU11248 Extends Life as Sutent Miracle With $48,720 Annual Bill, News PhotoSU11248 Extends Life as Sutent Miracle With $48,720 Annual Bill Get premium, high resolution news photos at Getty ImagesProduct #:97456340
AED1,850AED600
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
97456340
Collection:
Bloomberg
Date created:
08 October, 2009
Upload date:
Licence type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
SUTENT CANCER TREATMENT
Max file size:
3000 x 2000 px (31.75 x 21.17 cm) - 240 dpi - 807 KB